HGF/c‐MET pathway contributes to cisplatin‐mediated PD‐L1 expression in hepatocellular carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HGF/c‐MET pathway contributes to cisplatin‐mediated PD‐L1 expression in hepatocellular carcinoma
Authors
Keywords
-
Journal
CELL BIOLOGY INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-09-06
DOI
10.1002/cbin.11697
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LncRNA BANCR Attenuates the Killing Capacity of Cisplatin on Gastric Cancer Cell Through the ERK1/2 Pathway
- (2021) Xiang Miao et al. Cancer Management and Research
- PD-L1 as a biomarker of response to immune-checkpoint inhibitors
- (2021) Deborah Blythe Doroshow et al. Nature Reviews Clinical Oncology
- BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism
- (2021) Lifang Luo et al. Cell Death & Disease
- PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression
- (2021) Lijun Wu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance
- (2020) Isabella Giacomini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical Challenges of Immune Checkpoint Inhibitors
- (2020) Maria de Miguel et al. CANCER CELL
- Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1
- (2020) Shenghao Li et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion
- (2020) Linyong Du et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro
- (2020) Jianfei Xu et al. LIFE SCIENCES
- KIF14 and KIF23 Promote Cell Proliferation and Chemoresistance in HCC Cells, and Predict Worse Prognosis of Patients with HCC
- (2020) Chunxia Cheng et al. Cancer Management and Research
- Systemic treatment of HCC in special populations
- (2020) Lorenza Rimassa et al. JOURNAL OF HEPATOLOGY
- Nerigoside suppresses colorectal cancer cell growth and metastatic potential through inhibition of ERK/GSK3/-catenin signaling pathway
- (2019) Shi-Yuan Wen et al. PHYTOMEDICINE
- Inhibition of PI3K/mTOR increased the sensitivity of hepatocellular carcinoma cells to cisplatin via interference with mitochondrial‐lysosomal crosstalk
- (2019) Jiyao Sheng et al. CELL PROLIFERATION
- Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation
- (2019) Hongda Ding et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cisplatin contributes to programmed death-ligand 1 (PD-L1) expression in bladder cancer through ERK1/2 - AP-1 signaling pathway
- (2019) Te-Fu Tsai et al. BIOSCIENCE REPORTS
- Cisplatin-Induced Ototoxicity: Updates on Molecular Targets
- (2019) Erica Gentilin et al. TRENDS IN MOLECULAR MEDICINE
- Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer
- (2019) Ludovic Fournel et al. CANCER LETTERS
- EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression
- (2019) Shunli Peng et al. Molecular Cancer
- The role of microRNA in the resistance to treatment of hepatocellular carcinoma
- (2019) Muhammad Yogi Pratama et al. Annals of Translational Medicine
- Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
- (2018) Ming Yi et al. Molecular Cancer
- Recent advances in medical management of hepatocellular carcinoma
- (2018) Kenji Ikeda HEPATOLOGY RESEARCH
- Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition
- (2017) Yei-San Hsieh et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma
- (2017) Eleanna Papa et al. Cell Death & Disease
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment
- (2016) Stefan Hartmann et al. CLINICAL CANCER RESEARCH
- The hepatocyte growth factor (HGF)–MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions
- (2016) Subburaj Ilangumaran et al. CYTOKINE
- Hepatocyte growth factor: A regulator of inflammation and autoimmunity
- (2015) Nicolas Molnarfi et al. AUTOIMMUNITY REVIEWS
- Hepatocyte growth factor and Met in drug discovery
- (2015) K. Sakai et al. JOURNAL OF BIOCHEMISTRY
- Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
- (2015) Wasia Rizwani et al. Cancers
- Wnt signaling and hepatocarcinogenesis: Molecular targets for the development of innovative anticancer drugs
- (2013) Floriane Pez et al. JOURNAL OF HEPATOLOGY
- Hepatic Stellate Cells Secreted Hepatocyte Growth Factor Contributes to the Chemoresistance of Hepatocellular Carcinoma
- (2013) Guofeng Yu et al. PLoS One
- Wnt/β-catenin signalling in prostate cancer
- (2012) Robert M. Kypta et al. Nature Reviews Urology
- Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans
- (2011) Yeonghwan Kim et al. HEPATOLOGY
- Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma
- (2009) Anupam Bishayee et al. CANCER TREATMENT REVIEWS
- TGF-β1 targets the GSK-3β/β-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts
- (2008) F CARACI et al. PHARMACOLOGICAL RESEARCH
- HGF Increases Cisplatin Resistance via Down-Regulation of AIF in Lung Cancer Cells
- (2007) Jin-Tang Chen et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started